Carnegie Mellon University acquired a new stake in shares of Predictive Oncology Inc. (NASDAQ:POAI – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 10,358 shares of the medical instruments supplier’s stock, valued at approximately $34,000. Predictive Oncology comprises approximately 0.0% of Carnegie Mellon University’s holdings, making the stock its 5th biggest holding. Carnegie Mellon University owned about 0.26% of Predictive Oncology as of its most recent SEC filing.
Separately, Raymond James & Associates acquired a new position in shares of Predictive Oncology in the 3rd quarter valued at about $378,000. Hedge funds and other institutional investors own 9.04% of the company’s stock.
Predictive Oncology Stock Performance
NASDAQ POAI traded up $0.32 during mid-day trading on Thursday, reaching $1.66. 246,542 shares of the stock were exchanged, compared to its average volume of 29,666. The business’s 50 day moving average is $2.48 and its 200-day moving average is $2.92. Predictive Oncology Inc. has a 1 year low of $1.12 and a 1 year high of $7.12. The company has a market capitalization of $6.74 million, a P/E ratio of -0.48 and a beta of 1.28.
Predictive Oncology Profile
Predictive Oncology Inc operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.
Further Reading
- Five stocks we like better than Predictive Oncology
- Following Congress Stock Trades
- Hasbro’s Management Made All the Right Calls This Quarter
- Compound Interest and Why It Matters When Investing
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- Trading Stocks: RSI and Why it’s Useful
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Predictive Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Predictive Oncology and related companies with MarketBeat.com's FREE daily email newsletter.